SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001811764-23-000042
Filing Date
2023-08-14
Accepted
2023-08-14 10:22:59
Documents
8
Effectiveness Date
2023-08-14

Document Format Files

Seq Description Document Type Size
1 S-8 pnt_forms-8xevergreenincre.htm S-8 75836
2 EX-FILING FEES exhibit1071-formsx8filingf.htm EX-FILING FEES 17748
3 EX-5.1 exhibit51-opinionofbassber.htm EX-5.1 11088
4 EX-23.2 exhibit232-consentofarmani.htm EX-23.2 4695
5 bbs.jpg GRAPHIC 3438
6 image.jpg GRAPHIC 4812
7 image_0.jpg GRAPHIC 269
8 image_1.jpg GRAPHIC 5938
  Complete submission text file 0001811764-23-000042.txt   129787
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273965 | Film No.: 231167084
SIC: 2834 Pharmaceutical Preparations